News
This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...
MUSCAT: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies ...
Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second quarter ended June 30, 2025.
The agreement is for a planned clinical trial of AXPAXLI (also known as OTX-TKI) for the treatment of non-proliferative ...
GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.
Eye floaters, those drifting spots in your vision, are often harmless but can signal hypertension or diabetes. High blood ...
16h
India Today on MSNStudy links weight-loss drugs to serious eye conditions and vision loss
Weight-loss drugs Mounjaro and Wegovy gain popularity among Indian diabetes patients. New research highlights rare but ...
Two new JAMA Network Open studies link popular diabetes and weight loss drugs, including Ozempic and Mounjaro, to a slightly ...
12h
Onlymyhealth on MSNNew Study Links Weight Loss Drugs To Optic Nerve Disorders: Here's Everything Diabetes Patients Should Know
As weight loss drugs like Ozempic and Mounjaro gain a lot of attention worldwide a new study has revealed a rare side effect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results